Showing results (381-390 of 529) with videos related to
Sort By:
Pageof 53
Drug Development Research|January 18, 2024
Avian and Human Homologues of the P2Y1 Receptor: Pharmacological, Signaling, and Molecular PropertiesJosé L Boyer, Joel B Schachter, Susan M Sromek, et al.Cardiovascular and Interventional Radiology|June 9, 2018
Palliative Percutaneous Cryoablation and Cementoplasty of Acetabular Metastases: Factors Affecting Pain Control and Fracture RiskA Nicholas Kurup, Grant D Schmit, Thomas D Atwell, et al.Multiple Sclerosis and Related Disorders|September 10, 2023
Accelerometry measures of physical activity and sedentary behavior: Associations with cognitive functioning in MSHeena R Manglani, Madhura Phansikar, Elizabeth Jean Duraney, et al.Journal of Vascular and Interventional Radiology : JVIR|October 19, 2017
Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural ImagingThomas D Atwell, A Nicholas Kurup, Stephen A Boorjian, et al.Transplantation|July 8, 2015
Incidence and Outcome of C4d Staining With Tubulointerstitial Inflammation in Blood Group-incompatible Kidney TransplantationLionel Couzi, Ranmith Perera, Miriam Manook, et al.Cell Calcium|August 21, 2007
NAADP+ is an agonist of the human P2Y11 purinergic receptorIliana Moreschi, Santina Bruzzone, Nicoletta Bodrato, et al.Immuno|November 28, 2024
Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 DiabetesDequina A Nicholas, Jacques C Mbongue, Darysbel Garcia-Pérez, et al.Clinical Chemistry|December 1, 1980
Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatographyR G Buice, W E Evans, J Karas, et al.Health Promotion Practice|April 26, 2006
Coalition-based approaches for addressing environmental issues in childhood asthmaElisa A Nicholas, Maura Dwyer, Amy Murphy, et al.Multiple Sclerosis and Related Disorders|June 14, 2022
Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumabJacqueline A Nicholas, Mark Gudesblatt, Meghan Garabedian, et al.Pageof 53